Loading clinical trials...
Loading clinical trials...
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Conditions
Interventions
EMR-based BPA model
Placebo (EMR-based without BPA model)
Locations
2
United States
T1D Exchange
Boston, Massachusetts, United States
T1D Exchange
Boston, Massachusetts, United States
Start Date
August 13, 2024
Primary Completion Date
July 30, 2027
Completion Date
July 30, 2027
Last Updated
April 17, 2025
NCT07222137
NCT06807190
NCT07160816
NCT04786262
NCT06748963
NCT03648918
Lead Sponsor
T1D Exchange, United States
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions